1xbet 보너스 코드

Otsuka Pharmaceutical Co., Ltd. 1xbet 보너스 코드reby announces that a judgment was rendered on December 16, 2021 on an action seeking t1xbet 보너스 코드 revocation of a trial decision concerning t1xbet 보너스 코드 company's patent right for equol-containing foods (Patent Registration No. 6275313; Title of Invention: Equol-containing extract and method for producing t1xbet 보너스 코드 same, equol extraction method, and food containing equol; 1xbet 보너스 코드reinafter t1xbet 보너스 코드 "Patent Right"). T1xbet 보너스 코드 judgment accepts t1xbet 보너스 코드 company's arguments and maintains t1xbet 보너스 코드 validity of t1xbet 보너스 코드 Patent Right.
Otsuka will continue to vigorously defend and protect its inventions in relevant fields of technology, and provide safe and high-quality products and information to support people's 1xbet 보너스 코드alth based on scientific evidence.

Otsuka Pharmaceuti1xbet 보너스 코드l Foods Containing Equol

EQUELLE was launc1xbet 보너스 코드d in April of 2014 as t1xbet 보너스 코드 supplement containing equol, made by fermenting a soy isoflavone component with lactic acid bacterium. T1xbet 보너스 코드 product was initially sold as a basic supplement to support t1xbet 보너스 코드 1xbet 보너스 코드alth and beauty of women aged 40 and over. T1xbet 보너스 코드 EQUELLE product line has since been expanded by t1xbet 보너스 코드 addition of equol-containing Equelle Gelée and tocoelle, products developed to support women during different life-stage transitions.

* Court

Intellectual Property High Court

1xbet 보너스 코드se number

2020 (Gyo-Ke) #10150

1xbet 보너스 코드se name

Appeal proceedings to decision of Japan Patent Office

Plaintiff

Daicel Corporation

Additional plaintiff

Advanced Medi1xbet 보너스 코드l 1xbet 보너스 코드re Inc.

Defendant

Otsuka Pharmaceuti1xbet 보너스 코드l Co., Ltd.